Programs, populations, and payments verified via SAMHSA.
- Level of care
- Detox · Inpatient · IOP · MAT · Telehealth
- Service settings
- Hospital inpatient/24-hour hospital inpatient, Outpatient, Hospital inpatient detoxification, Hospital inpatient treatment, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment
- Therapy approaches
- Brief intervention, Cognitive behavioral therapy, Contingency management/motivational incentives, Motivational interviewing, Relapse prevention, Substance use disorder counseling, Trauma-related counseling, Telemedicine/telehealth therapy
- Age groups
- Children/Adolescents
- Special populations
- Adolescents, Clients with co-occurring mental and substance use disorders
- Medications used
- Acamprosate (Campral®), Buprenorphine sub-dermal implant, Buprenorphine with naloxone, Buprenorphine (extended-release, injectable), Naltrexone (extended-release, injectable)
- Recovery supports
- Self-help groups, Recovery coach, Mentoring/peer support, Employment counseling or training
- Facility operation
- Private non-profit organization